Methoxsalen
- TRADE NAMES: Geroxalen; Meladinine; Oxsoralen (Valeant); Oxsoralon; Puvasoralen; Ultra-MOP
- INDICATIONS: Psoriasis, vitiligo
- CLASS: CYP1A2 inhibitor, Psoralen, Repigmenting agent
- HALF-LIFE: 1.1 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Caffeine, Chloroquine, Cyclosporine, Fluoroquinolones, Phenothiazines, Sulfonamides
PREGNANCY CATEGORY: C
Potential hazards of long-term therapy include the possibilities of carcinogenicity and cataractogenicity.
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
OCULAR.
Page last updated 10/27/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
